ACET (adicetbio.com) Sof foyda

ACET (adicetbio.com) - kompaniyaning tovar belgisi

Adicet Bio (ACET) uchun xavflar autoimmun patologiya terapiyasi sinovlarining noaniqligi va naqd pullarning tez sarflanish sur'ati bilan bog'liq. Kompaniyaning sof foyda darajasi ushbu qiyinchiliklarni aks ettiradi, bunda -0.10 belgisi joriy ko'rsatkich vazifasini o'taydi. Egri chiziqning barqarorligi moliyaviy asosni tasdiqlaydi, hujayraviy tibbiyotdagi nufuzi va hujayralarni modifikatsiya qilish usullari uchun patent himoyasi esa arzon generik dori vositalarining paydo bo'lishi xavfini minimallashtiradi.

ACET (Adicet Bio) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

adicetbio.com (ACET) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Adicet Bio, Inc.|ACET - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Adicet Bio, Inc.|ACET - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Adicet Bio|ACET - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi adicetbio.com|ACET - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Adicet Bio|ACET - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Adicet Bio, Inc.|ACET - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Adicet Bio, Inc.|ACET - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Adicet Bio|Shoshilinch likvidlik adicetbio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ACET - Sof foyda
Kompaniyaning jamlanma tahlili:Adicet Bio
Adicet Bio Inc. asosiy tovari

Ushbu ko'rsatkich real pul oqimining kunlik dinamikasini aks ettirib, bozor talqinlaridan qat'i nazar, biznesning qo'shimcha qiymat yaratish qobiliyatini ob'ektiv baholash imkonini beradi. Daromadlari hujayra terapiyasi tijoratlashtirilishiga bog'liq bo'lgan Adicet Bio (ACET) uchun kompaniyaning sof foydasini tahlil qilish moliyaviy hisobotlar rasman e'lon qilinishidan oldin fundamental zaiflikni yoki o'sish potentsialini aniqlashga yordam beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|PHAR - Sof foyda|NKTR: Sof foyda|Kompaniya foydasi UPB|ZBIO (Zenas Biopharma) - Sof foyda|Immunome Inc (IMNM) - Sof moliyaviy natija|Sof foyda GOSS|Sof daromad KalVista Corp KALV|Sof foyda SEPN (Septerna Inc)|pieris.com (PVLA) - Kompaniyaning sof daromadi|SVRA: Sof daromad|Rigel Pharma - Soliqlar to‘langandan keyingi foyda|ANAB (AnaptysBio Corp) - Sof daromad|Astria Corp - Yakuniy foyda|ENGN (enGene Holdings Inc.) - Sof foyda|Kompaniyaning sof foydasi RAPT|Sof foyda JBIO|Sof moliyaviy natija Aclaris Therapeutics Inc.|Kompaniyaning sof foydasi Kyverna KYTX|Tiziana Life Sciences, Ltd. (TLSA) - Kompaniyaning sof daromadi|Cabaletta Bio, Inc. - Sof foyda|VTYX - Sof foyda|THTX: Sof foyda|Sof daromad Avalo Therapeutics, Inc.|ELDN (Eledon) - Sof foyda|Kompaniyaning sof daromadi Agenus, Inc AGEN|Sof daromad CLYM (Climb Bio Inc)|Soliqlar to‘langandan keyingi foyda ZURA|Kompaniyaning sof foydasi aTyr Pharma ATYR|ADAG (Adagene Inc) - Soliqdan keyingi foyda|Ikena Oncology, Inc. - Sof foyda|Yakuniy foyda STTK (Shattuck Labs, Inc.)|EQ: Sof foyda|Connect Biopharma Holdings Limited (CNTB) - Sof foyda|Kompaniyaning sof foydasi Immunic Therapeutics|ATRA: Yakuniy foyda|Kompaniyaning sof foydasi InflaRx N.V. (IFRX)|Sof daromad X4 Pharmaceuticals, Inc XFOR|Sof foyda CELU (Celularity)|Sof foyda inmunebio.com INMB|BRNS: Sof daromad|Yakuniy foyda KZR (Kezar Life Sciences Inc.)|SABS: Sof foyda|AKTX - Sof moliyaviy natija|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Sof daromad Q32 Bio Corp (QTTB)|Kompaniyaning sof foydasi GeoVax (GOVX)|Sof daromad Edesa Biotech Inc EDSA|iBio Corp - Sof daromad|Sof foyda Carisma Therapeutics Inc CARM|XTLB - Kompaniyaning sof foydasi|BOLT (Bolt Biotherapeutics) - Kompaniya foydasi|HCWB: Sof foyda|Kompaniyaning sof daromadi Aptevo Therapeutics Inc. (APVO)|AIM (AIM ImmunoTech) - Sof foyda|Sof foyda Aditxt Corp|Sof foyda GRI|xortx.com - Kompaniya foydasi|Sof foyda HIND (Vyome Holdings)|Sof moliyaviy natija Revelation Biosciences Inc (REVB)|Indaptus - Sof foyda|BiondVax Pharmaceuticals (SCNI) - Sof daromad|CALI: Sof foyda|Kompaniyaning sof daromadi Affimed N.V. (AFMD)|Sof daromad ALLK|HOOK (HOOKIPA) - Soliqlar to‘langandan keyingi foyda|Sof daromad IGMS (IGM Biosciences, Inc.)|ITOS (iTeos Pharma) - Yakuniy foyda|Sof foyda OCEA (Ocean Biomedical, Inc.)|tcbiopharm.com - Kompaniyaning sof foydasi|Third Harmonic Bio, Inc. - Sof foyda